Thomas Brown

Array ( [id] => 5727614 [patent_doc_number] => 20060058375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Method of treating dry eye disorders and uveitis' [patent_app_type] => utility [patent_app_number] => 11/268301 [patent_app_country] => US [patent_app_date] => 2005-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3946 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058375.pdf [firstpage_image] =>[orig_patent_app_number] => 11268301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748466 [patent_doc_number] => 20060111398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Therapeutic use of farnesyltransferase inhibitors and methods of monitoring the efficacy thereof' [patent_app_type] => utility [patent_app_number] => 11/265445 [patent_app_country] => US [patent_app_date] => 2005-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 23774 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111398.pdf [firstpage_image] =>[orig_patent_app_number] => 11265445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748411 [patent_doc_number] => 20060111343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Oxcarbazepine dosage forms' [patent_app_type] => utility [patent_app_number] => 11/264836 [patent_app_country] => US [patent_app_date] => 2005-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4426 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111343.pdf [firstpage_image] =>[orig_patent_app_number] => 11264836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5807204 [patent_doc_number] => 20060093558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Post-foaming dental mousse and methods utilizing the same' [patent_app_type] => utility [patent_app_number] => 11/260116 [patent_app_country] => US [patent_app_date] => 2005-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3151 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20060093558.pdf [firstpage_image] =>[orig_patent_app_number] => 11260116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760823 [patent_doc_number] => 20060211768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor' [patent_app_type] => utility [patent_app_number] => 11/256501 [patent_app_country] => US [patent_app_date] => 2005-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11901 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211768.pdf [firstpage_image] =>[orig_patent_app_number] => 11256501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5716104 [patent_doc_number] => 20060079467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions' [patent_app_type] => utility [patent_app_number] => 11/254433 [patent_app_country] => US [patent_app_date] => 2005-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20250 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079467.pdf [firstpage_image] =>[orig_patent_app_number] => 11254433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5637006 [patent_doc_number] => 20060067979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Ophthalmic drug release device for multiple drug release' [patent_app_type] => utility [patent_app_number] => 11/236947 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3201 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20060067979.pdf [firstpage_image] =>[orig_patent_app_number] => 11236947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8592013 [patent_doc_number] => 08349889 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-08 [patent_title] => 'Skin-care preparations containing mupirocin and betamethasone dipropionate' [patent_app_type] => utility [patent_app_number] => 12/065352 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3903 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12065352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5637035 [patent_doc_number] => 20060068008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Lyophilized pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/230193 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4680 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20060068008.pdf [firstpage_image] =>[orig_patent_app_number] => 11230193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754689 [patent_doc_number] => 20060223838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Methods and compositions for the treatment of hyperlipidemia' [patent_app_type] => utility [patent_app_number] => 11/229339 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20519 [patent_no_of_claims] => 109 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223838.pdf [firstpage_image] =>[orig_patent_app_number] => 11229339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4726807 [patent_doc_number] => 20080206348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Cilostazol-Containing Pharmaceutical Composition Based On Particles Of Less Than 50 Micrometers' [patent_app_type] => utility [patent_app_number] => 11/575000 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3091 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206348.pdf [firstpage_image] =>[orig_patent_app_number] => 11575000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726439 [patent_doc_number] => 20060057199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Orally disintegrating tablets of atomoxetine' [patent_app_type] => utility [patent_app_number] => 11/223819 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4699 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057199.pdf [firstpage_image] =>[orig_patent_app_number] => 11223819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648480 [patent_doc_number] => 20060134212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Lercanidipine immediate release compositions' [patent_app_type] => utility [patent_app_number] => 11/218820 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8555 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134212.pdf [firstpage_image] =>[orig_patent_app_number] => 11218820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10534254 [patent_doc_number] => 09259872 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Multiparticulates' [patent_app_type] => utility [patent_app_number] => 11/661478 [patent_app_country] => US [patent_app_date] => 2005-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 8962 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11661478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5873172 [patent_doc_number] => 20060165796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Extended release formulation of levetiracetam' [patent_app_type] => utility [patent_app_number] => 11/215947 [patent_app_country] => US [patent_app_date] => 2005-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5248 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165796.pdf [firstpage_image] =>[orig_patent_app_number] => 11215947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835465 [patent_doc_number] => 20060247296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide' [patent_app_type] => utility [patent_app_number] => 10/535004 [patent_app_country] => US [patent_app_date] => 2005-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16039 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247296.pdf [firstpage_image] =>[orig_patent_app_number] => 10535004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9503499 [patent_doc_number] => 08741812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Class of sterol ligands and their uses in regulation of cholesterol and gene expression' [patent_app_type] => utility [patent_app_number] => 11/212031 [patent_app_country] => US [patent_app_date] => 2005-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18878 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11212031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801525 [patent_doc_number] => 20060035926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Benzothiazolium compounds' [patent_app_type] => utility [patent_app_number] => 11/204791 [patent_app_country] => US [patent_app_date] => 2005-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4162 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035926.pdf [firstpage_image] =>[orig_patent_app_number] => 11204791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 71988 [patent_doc_number] => 07754754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-13 [patent_title] => 'Pharmaceutical formulations containing substituted 2 heteroarylaminoacetic acid compounds' [patent_app_type] => utility [patent_app_number] => 11/202074 [patent_app_country] => US [patent_app_date] => 2005-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8565 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/754/07754754.pdf [firstpage_image] =>[orig_patent_app_number] => 11202074 [rel_patent_id] =>[rel_patent_doc_number] =>)